Targeted delivery of topotecan via folic acid functionalized phycocyanin nanoparticles for ovarian cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Breakthrough. This abstract does not ...
FDA approved pembrolizumab and berahyaluronidase alfa-pmph for patients aged 12 and older with solid tumors. Study MK-3475A-D77 showed a 45% ORR in subcutaneous administration for treatment-naïve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results